IC
FATE icon

IEQ Capital’s Fate Therapeutics FATE Stock Holding History

IEQ Capital’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Buy
487,728
+162,940
+50% +$302K 0.01% 991
2026
Q1 		$390K Buy
324,788
+203,287
+167% +$248K ﹤0.01% 1412
2025
Q4 		$119K Sell
121,501
-16,060
-12% -$19.3K ﹤0.01% 1749
2025
Q3 		$173K Buy
137,561
+20,504
+18% +$22.1K ﹤0.01% 1701
2025
Q2 		$131K Buy
117,057
+42,551
+57% +$49.5K ﹤0.01% 1685
2025
Q1 		$58.9K Buy
+74,506
New +$91.3K ﹤0.01% 1538

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IEQ Capital's FATE Position: Q2 2026 in Review

IEQ Capital increased its Fate Therapeutics (FATE) stake by 50% in Q2 2026, buying an estimated $302K and bringing the position to 487,728 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #991.

IEQ Capital first reported a position in FATE in Q1 2025 and has held it in 6 quarters since. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • IEQ Capital held 487,728 shares of Fate Therapeutics worth $1.32M as of Q2 2026.
  • IEQ Capital bought 162,940 Fate Therapeutics shares in Q2 2026, an estimated $302K.
  • Fate Therapeutics made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #991 holding.
  • IEQ Capital first reported a position in Fate Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.